STATIN-FIBRATE COMBINATIONS WITH SECONDARY EFFECTS IN REDUCED FAST-FASTING.

摘要

A dosage form of a pharmaceutical composition comprising a combination of a statin and fenofibrate microparticles that are stabilized by a phospholipid surfactant, in which the dosage form provides a therapeutically effective dose of a patient with statin and fenofibrate treatment the statin and a therapeutically effective amount of active fenofibrate species to said patient when fasting that is at least 80% of the amount of active fenofibrate species provided by said amount to said patient when fed with a meal containing fat .